Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
01 1ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. Sanmen CN
02 1NEULAND LABORATORIES LIMITED Hyderabad IN
03 1TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
04 1ALEMBIC PHARMACEUTICALS LIMITED Vadodara IN
05 1AMOLI ORGANICS PRIVATE LIMITED Mumbai IN
06 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
07 1BIOCON LIMITED Bengaluru IN
08 1CTX LIFESCIENCES PVT. LIMITED Surat IN
09 1GLENMARK LIFE SCIENCES LIMITED Mumbai IN
10 1MSN LABORATORIES PRIVATE LIMITED Rudraram Village IN
11 1SYMED LABS LIMITED Hyderabad IN
01 11Deferasirox
01 1China
02 9India
03 1Israel
01 11Valid
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Certificate Number : CEP 2024-292 - Rev 00
Status : Valid
Issue Date : 2024-12-18
Type : Chemical
Substance Number : 2933
Certificate Number : CEP 2020-280 - Rev 02
Status : Valid
Issue Date : 2024-03-20
Type : Chemical
Substance Number : 2933
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : R0-CEP 2021-111 - Rev 00
Status : Valid
Issue Date : 2023-04-11
Type : Chemical
Substance Number : 2933
Certificate Number : R0-CEP 2021-170 - Rev 02
Status : Valid
Issue Date : 2023-03-30
Type : Chemical
Substance Number : 2933
Certificate Number : CEP 2021-176 - Rev 00
Status : Valid
Issue Date : 2023-10-23
Type : Chemical
Substance Number : 2933
Certificate Number : CEP 2020-348 - Rev 02
Status : Valid
Issue Date : 2024-08-28
Type : Chemical
Substance Number : 2933
Certificate Number : R0-CEP 2021-493 - Rev 00
Status : Valid
Issue Date : 2023-07-12
Type : Chemical
Substance Number : 2933
Certificate Number : R0-CEP 2021-148 - Rev 00
Status : Valid
Issue Date : 2023-04-04
Type : Chemical
Substance Number : 2933
Certificate Number : R0-CEP 2021-037 - Rev 00
Status : Valid
Issue Date : 2023-03-10
Type : Chemical
Substance Number : 2933
Certificate Number : R0-CEP 2021-038 - Rev 00
Status : Valid
Issue Date : 2023-07-07
Type : Chemical
Substance Number : 2933
A Deferasirox manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deferasirox, including repackagers and relabelers. The FDA regulates Deferasirox manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deferasirox API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deferasirox manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deferasirox supplier is an individual or a company that provides Deferasirox active pharmaceutical ingredient (API) or Deferasirox finished formulations upon request. The Deferasirox suppliers may include Deferasirox API manufacturers, exporters, distributors and traders.
click here to find a list of Deferasirox suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Deferasirox CEP of the European Pharmacopoeia monograph is often referred to as a Deferasirox Certificate of Suitability (COS). The purpose of a Deferasirox CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Deferasirox EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Deferasirox to their clients by showing that a Deferasirox CEP has been issued for it. The manufacturer submits a Deferasirox CEP (COS) as part of the market authorization procedure, and it takes on the role of a Deferasirox CEP holder for the record. Additionally, the data presented in the Deferasirox CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Deferasirox DMF.
A Deferasirox CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Deferasirox CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Deferasirox suppliers with CEP (COS) on PharmaCompass.
We have 11 companies offering Deferasirox
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?